Pompidou Group – Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs
Budapest 28-29 May 2019
Police and customs representatives from 12 countries of the South-East Europe region strengthened...
Lisbon 28-29 May 2019
The 84th plenary meeting of the Pompidou Group’s Permanent Correspondents took place in Lisbon,...
2019 Pompidou Group Executive Training on ‘Incorporating gender dimensions in drug policy practice and service delivery’Amsterdam 2-5 April 2019
30 participants from 20 countries from different continents successfully completed the Module I...
2019 regional report on substance use in focus of the 10th meeting of the Mediterranean committee for school surveysParis 10-11 April 2019
The MedSPAD Committee, currently made up of representatives from 14 countries (Algeria, Croatia,...
Vienna 14-22 March 2019
As in previous years, the Pompidou Group took part in the yearly session of the Commission on...
Learn about the Pompidou Group's approach on bringing Human Rights to the forefront of drug policy
There is a need to have processes in place for on-going assessment to ensure that human rights are and remain respected and safeguarded. Policy makers, policy implementers and policy evaluators must be aware and mindful of the human rights dimension that should inspire their choices and decisions. The Pompidou Group stresses this need in its 2017 statement on bringing human rights into drug policy. The statement confirms the member states’ categorical opposition to the death penalty and condemns extrajudicial executions, arbitrary detention and inhuman or degrading treatment or punishment. Member states also express their commitment to good democratic governance principles and to reducing the stigma of drug users, and acknowledge indicators that can be relied upon when conducting a human rights-based review of drug policy.
- Statement on bringing human rights into drug policy development, implementation, monitoring and evaluation
- Background paper ‘Drug policy and Human Rights in Europe: Managing tensions, maximizing complementarities’
- Statement on costs and spill-over consequences of drug policies
Approximately 60-70% of the general population experience a traumatic event at some point in their lifetime, which can include forms of violence, abuse, neglect and war. Post-Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD) are often concurrent and develop as a result of a person being exposed to a traumatic event.
Therefore, part of providing adequate health service is responding correctly to the effects of trauma.
The latest Pompidou Group paper addresses this issue, by providing guidance on psychosocial support to tackle trauma-related symptoms and related substance use disorders, in particular among refugees, internally displaced persons and war veterans as groups especially vulnerable to PTSD.